1. Cranial nerve palsy in Wegener’s granulomatosis – Lessons from clinical cases

   • R. Nowack
   • P. Wachtler
   • N. Rasmussen

   REVIEW 01 March 2009 Pages: 299 - 304

2. Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis

   • M. Kolappan
   • A. P. D. Henderson
   • D. H. Miller

   REVIEW 18 March 2009 Pages: 305 - 319

3. Acquired hepatocerebral degeneration

   • J. Ferrara
   • J. Jankovic

   REVIEW 17 February 2009 Pages: 320 - 332

4. Epidemiology of vertigo, migraine and vestibular migraine

   • T. Lempert
   • H. Neuhauser

   REVIEW 17 February 2009 Pages: 333 - 338

5. Case-control study of thromboembolic events associated with IV immunoglobulin

   • J. B. Caress
   • L. Hobson-Webb
   • M. S. Cartwright

   ORIGINAL COMMUNICATION 01 March 2009 Pages: 339 - 342

6. The genetic aetiology of late-onset chronic progressive cerebellar ataxia

   • Mark Wardle
   • Elisa Majounie
   • Neil P. Robertson

   ORIGINAL COMMUNICATION 06 March 2009 Pages: 343 - 348

7. Fatigue, pain and muscle weakness are frequent after Guillain-Barré syndrome and poliomyelitis

   • T. Rekand
   • A. Gramstad
   • C. A. Vedeler

   ORIGINAL COMMUNICATION 06 March 2009 Pages: 349 - 354

8. MRI and clinical syndrome in dura materrelated Creutzfeldt-Jakob disease

   • B. Meissner
   • K. Kallenberg
   • I. Zerr

   ORIGINAL COMMUNICATION Open access 23 January 2009 Pages: 355 - 363

9. The costs and prognostic characteristics of ischaemic neurological deficit due to subarachnoid haemorrhage in the United Kingdom

   • Oliver Rivero-Arias
   • Jane Wolstenholme
   • Mary Sneade

   ORIGINAL COMMUNICATION 09 February 2009 Pages: 364 - 373

10. Natural history comparisons of primary and secondary progressive multiple sclerosis reveals differences and similarities

    • H. Tremlett
    • Y. Zhao
    • and the UBC Neurologists

    ORIGINAL COMMUNICATION 18 March 2009 Pages: 374 - 381

11. Is the left uncinate fasciculus essential for language?

    • H. Duffau
    • P. Gatignol
    • E. Mandonnet

    ORIGINAL COMMUNICATION 06 March 2009 Pages: 382 - 389

12. Reversible Pisa syndrome in patients with Parkinson’s disease on dopaminergic therapy

    • A. Cannas
    • P. Solla
    • M. G. Marrosu

    ORIGINAL COMMUNICATION 18 March 2009 Pages: 390 - 395

13. Contemporary Encephalitis Lethargica: Phenotype, laboratory findings and treatment outcomes

    • Robert Lopez-Alberola
    • Michael Georgiou
    • Spyridon Papapetropoulos

    ORIGINAL COMMUNICATION 06 March 2009 Pages: 396 - 404

14. The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL

    • M. Hutchinson
    • L. Kappos
    • for the AFFIRM and SENTINEL Investigators

    ORIGINAL COMMUNICATION 18 March 2009 Pages: 405 - 415

15. Pontocerebellar hypoplasia type III (CLAM): Extended phenotype and novel molecular findings

    • B. Durmaz
    • B. Wollnik
    • F. Ozkinay

    ORIGINAL COMMUNICATION 14 March 2009 Pages: 416 - 419

16. Ocular fixation instabilities in motor neurone disease

    • C. Donaghy
    • R. Pinnock
    • J. M. Gibson

    ORIGINAL COMMUNICATION 18 March 2009 Pages: 420 - 426

17. Grey matter magnetization transfer ratio independently correlates with neurological deficit in secondary progressive multiple sclerosis

    • T. Hayton
    • J. Furby
    • R. Kapoor

    ORIGINAL COMMUNICATION 06 March 2009 Pages: 427 - 435

18. “Vestibular migraine”: effects of prophylactic therapy with various drugs

    • B. Baier
    • E. Winkenwerder
    • M. Dieterich

    ORIGINAL COMMUNICATION 06 March 2009 Pages: 436 - 442

19. Quality of life in survivors after cervical artery dissection

    • U. Fischer
    • I. Ledermann
    • M. Arnold

    ORIGINAL COMMUNICATION 18 March 2009 Pages: 443 - 449

20. Distal and proximal prehension is differentially affected by Parkinson‘s disease

    • P. H. Weiss
    • M. Dafotakis
    • J. Noth

    ORIGINAL COMMUNICATION 06 March 2009 Pages: 450 - 456

21. Obstacle stepping in patients with Parkinson’s disease

    • J. Michel
    • D. Benninger
    • H. J. A. van Hedel

    ORIGINAL COMMUNICATION 06 March 2009 Pages: 457 - 463

22. Predicting recovery after intracerebral hemorrhage – An external validation in patients from controlled clinical trials

    • C. Weimar
    • A. Ziegler
    • on behalf of the VISTA investigators

    ORIGINAL COMMUNICATION 18 March 2009 Pages: 464 - 469

23. Influence of task complexity during coordinated hand and foot movements in MS patients with and without fatigue

    • M. A. Rocca
    • R. Gatti
    • M. Filippi

    ORIGINAL COMMUNICATION 06 March 2009 Pages: 470 - 482

24. The leucine rich repeat kinase 2 (LRRK2) G2019S substitution mutation

    • Sharon Hassin-Baer
    • Yael Laitman
    • Eitan Friedman

    ORIGINAL COMMUNICATION 24 March 2009 Pages: 483 - 487

25. Chocolate consumption is increased in Parkinson’s disease

    • M. Wolz
    • A. Kaminsky
    • H. Reichmann

    ORIGINAL COMMUNICATION 13 March 2009 Pages: 488 - 492

26. Apolipoprotein E genotype as a risk factor for susceptibility to and dementia in Parkinson’s Disease

    • C. H. Williams-Gray
    • A. Goris
    • R. A. Barker

    ORIGINAL COMMUNICATION 18 March 2009 Pages: 493 - 498

27. Acute cervical radiculopathies in spontaneous intracranial hypotension

    • K. A. Kleopa
    • K. Natsiopoulos

    LETTER TO THE EDITORS 13 March 2009 Pages: 499 - 501

28. Alois Alzheimer (1864–1915)

    • F. R. J. Verhey

    PIONEERS IN NEUROLOGY 18 March 2009 Pages: 502 - 503

29. Arnold Pick (1851–1924)

    • D. Todman

    PIONEERS IN NEUROLOGY 05 March 2009 Pages: 504 - 505

30. The efficacy of novel treatments for well-known diseases

    • Michael Strupp

    JOURNAL CLUB Pages: 506 - 508

31. Communications of the European Neurological Society

    • Clay E. Reilly

    COMMUNICATIONS Pages: 509 - 512